HR 909, the Crime Victims Fund Stabilization Act of 2025, modifies how funds from the False Claims Act are deposited into the Crime Victims Fund. It specifies that from 2025 through 2029, certain False Claims Act proceeds (specifically those for qui tam plaintiff payments and government damage reimbursements) cannot be deposited into the fund. This change directly affects the composition of the Crime Victims Fund by excluding these specific revenue streams during the specified period. The bill does not create new benefits or alter victim services; it only adjusts fund allocation rules for existing False Claims Act revenues.
SRES 288 is a Senate resolution condemning recent ideologically motivated attacks on Jewish individuals, including a violent assault in Boulder, Colorado, on June 1, 2025, and other incidents like the attack on Israeli Embassy staff in Washington, D.C., and fires at the Pennsylvania Governor’s Residence. The resolution formally expresses the Senate’s condemnation of these acts as part of a growing pattern of antisemitism and politically motivated violence. It reaffirms the Senate’s commitment to protecting peaceful assembly and religious practice, while urging federal, state, and local law enforcement to thoroughly investigate such incidents and calling on community leaders to publicly oppose antisemitism. This resolution has no legal effect but serves as a formal statement of the Senate’s position.
HR 3492, the Protect Children’s Innocence Act, makes it a federal crime to perform genital or bodily mutilation or chemical castration on minors under 18, except for specific medical reasons. The bill broadly defines prohibited procedures to include gender transition-related surgeries (like hysterectomies or mastectomies) and medical treatments such as puberty blockers or cross-sex hormones administered to minors. It criminalizes these acts when they occur across state lines, involve payments, or use interstate commerce, while explicitly banning religious tradition as a defense. Exceptions include medically necessary procedures for health emergencies, childbirth, or conditions certified by a physician.
The Kayla Hamilton Act amends rules for placing unaccompanied immigrant children under 12 in foster care. It requires the Health and Human Services Secretary to contact the child's country of origin for criminal records, check for gang-related tattoos/markings, and place children with gang ties in secure facilities. The bill also mandates detailed background checks for host families, including immigration status, criminal history, and sex offender registry checks, before placement. These changes directly affect unaccompanied immigrant children in federal custody and the agencies managing their placements. The law aims to strengthen safeguards during the placement process without altering existing trafficking prevention programs.
HR 5810, the Federal Supervisor Education Act of 2025, requires all federal supervisors to complete mandatory training on key management responsibilities. The bill mandates agencies to establish programs covering performance goal-setting, fair workplace practices, addressing harassment, disciplinary procedures, and probationary evaluations. Supervisors must complete initial training within one year of appointment and refresher training every three years. The law directly affects every federal supervisor, including management officials and designated employees, by requiring structured development aligned with agency missions and OPM guidelines. It also requires agencies to measure training effectiveness and provide supervisors with developmental opportunity resources.
Strengthening Agency Management and Oversight of Software Assets Act This bill requires federal agencies and Intelligence Community (IC) elements to assess their software inventory and develop software management plans. The bill requires each agency and each IC element to complete a comprehensive assessment of the software paid for by, in use at, or deployed throughout the agency or element. The assessment must include information such as (1) the current inventory of software; (2) contracts and other arrangements used to acquire, build, deploy, or use the software; (3) costs and fees not included in the initial contract or agreement; and (4) the interoperability of the software and restrictions on its use. Each agency and IC element must use their assessment to develop a plan to consolidate software entitlements, develop procedures for cost-effective acquisition strategies, and restrict subordinate entities from using any software entitlement without approval. (A software entitlement is software that has been purchased, leased, or licensed by or billed to an agency and that is subject to use limitations.) Such plans must be submitted to the Office of Management and Budget (OMB) and Congress. Within two years of enactment, OMB must submit recommendations to Congress regarding government software procurement policies and practices to • increase the interoperability of software licenses; • consolidate licenses when appropriate; • reduce costs; • improve performance; and • modernize the management and oversight of agency software. The GAO must report on certain related topics, including governmentwide trends in agency software asset management practices and comparisons of such practices among agencies.
The Protect America's Workforce Act cancels an executive order issued on March 27, 2025, that excluded certain groups from federal labor-management relations programs, making it legally unenforceable. It also ensures that all collective bargaining agreements between federal agencies and labor unions, which were active as of March 26, 2025, remain fully effective until their agreed terms expire. This directly affects federal agencies, labor unions, and the employees covered by these agreements. The bill prevents federal funds from being used to implement the canceled executive order while preserving existing labor agreements.
This bill directs the American Battle Monuments Commission to correct historical errors by identifying Jewish World War I and II veterans buried overseas under incorrect Christian markers (Latin crosses) and replacing them with appropriate markers. It establishes a 10-year program to contact families of affected veterans, with the Commission funding the effort at $500,000 annually through nonprofit contracts. The program specifically targets veterans buried in foreign U.S. military cemeteries with markers indicating non-Jewish faith, addressing a documented mistake affecting approximately 900 Jewish servicemembers. This directly affects Jewish veterans' families by honoring their heritage and correcting past burial inaccuracies.
SRES 536 is a non-binding Senate resolution designating December 2, 2025, as "World Nuclear Energy Day." It commemorates nuclear energy's role in clean power generation, highlighting historical milestones like the first nuclear chain reaction (1942) and the first commercial nuclear plant (1957). The resolution celebrates nuclear energy's contributions to U.S. electricity (18% of generation, 43% carbon-free), job creation (over 70,000 direct jobs), and national security, without creating new laws or affecting any group. It serves as a symbolic recognition of the industry's achievements.
This bill amends the Natural Gas Act to give the Federal Energy Regulatory Commission (FERC) exclusive authority to approve U.S. LNG export terminal projects, requiring FERC to deem such exports consistent with the public interest. It directly affects natural gas companies seeking to build or expand export facilities and streamlines FERC's review process by removing prior requirements for interagency coordination. The bill clarifies that FERC's decisions won't override existing sanctions laws, including restrictions on trade with countries designated as state sponsors of terrorism under current law. This change aims to accelerate domestic LNG export projects while maintaining legal safeguards for national security and foreign policy.
HR 4431, the Improving Capital Allocation for Newcomers Act of 2025, changes rules for certain venture capital funds under the Investment Company Act of 1940. It raises the maximum number of investors allowed from 250 to 2,000 and increases the asset threshold from $10 million to $150 million for funds seeking an exemption. This directly affects venture capital funds that want to operate under the 3(c)(1) exemption, allowing them to pool capital from more investors and manage larger funds without full SEC registration. The bill makes these specific numerical adjustments to the existing exemption rules.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
